These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 22393444

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection.
    Martins TG, Trigo G, Fraga AG, Gama JB, Longatto-Filho A, Saraiva M, Silva MT, Castro AG, Pedrosa J.
    PLoS Negl Trop Dis; 2012; 6(11):e1925. PubMed ID: 23209864
    [Abstract] [Full Text] [Related]

  • 3. Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model.
    Trigo G, Martins TG, Fraga AG, Longatto-Filho A, Castro AG, Azeredo J, Pedrosa J.
    PLoS Negl Trop Dis; 2013; 7(4):e2183. PubMed ID: 23638204
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.
    Ruf MT, Schütte D, Chauffour A, Jarlier V, Ji B, Pluschke G.
    Antimicrob Agents Chemother; 2012 Feb; 56(2):687-96. PubMed ID: 22143518
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice.
    Almeida D, Converse PJ, Ahmad Z, Dooley KE, Nuermberger EL, Grosset JH.
    PLoS Negl Trop Dis; 2011 Jan 04; 5(1):e933. PubMed ID: 21245920
    [Abstract] [Full Text] [Related]

  • 11. Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infection.
    Zhang T, Li SY, Converse PJ, Almeida DV, Grosset JH, Nuermberger EL.
    Antimicrob Agents Chemother; 2011 Jan 04; 55(1):56-61. PubMed ID: 21078940
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
    Converse PJ, Almeida DV, Tyagi S, Xu J, Nuermberger EL.
    Antimicrob Agents Chemother; 2019 Jul 04; 63(7):. PubMed ID: 31036687
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin.
    Schütte D, Um-Boock A, Mensah-Quainoo E, Itin P, Schmid P, Pluschke G.
    PLoS Negl Trop Dis; 2007 Oct 31; 1(1):e2. PubMed ID: 17989779
    [Abstract] [Full Text] [Related]

  • 19. Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.
    Dega H, Bentoucha A, Robert J, Jarlier V, Grosset J.
    Antimicrob Agents Chemother; 2002 Oct 31; 46(10):3193-6. PubMed ID: 12234844
    [Abstract] [Full Text] [Related]

  • 20. Rapid, serial, non-invasive assessment of drug efficacy in mice with autoluminescent Mycobacterium ulcerans infection.
    Zhang T, Li SY, Converse PJ, Grosset JH, Nuermberger EL.
    PLoS Negl Trop Dis; 2013 Oct 31; 7(12):e2598. PubMed ID: 24367713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.